Cover Image

Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis

Background: Tirzepatide-a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist-is used to treat type 2 diabetes. However, the efficacy and safety of tirzepatide in patients undergoing hemodialysis remain unclear.Methods: We conducted a single-center retrospectiv...

Full description

Saved in:

Bibliographic Details
Main Authors:	Emiko Otsuka (Author), Mineaki Kitamura (Author), Satoshi Funakoshi (Author), Hiroshi Mukae (Author), Tomoya Nishino (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tirzepatide for type 2 diabetes
by: Sarah L Anderson, et al.
Published: (2023)

The Tirzepatide Drop: Beware of Slimmer's Paralysis
by: John M. Tucker MD, et al.
Published: (2024)

Tirzepatide - A Revolution in Obesity Treatment?
by: Aleksandra Jaroń, et al.
Published: (2024)

Treatment of insulin resistance with tirzepatide leading to improvement of hair loss
by: Emily R. Gordon, BA, et al.
Published: (2024)

Dulaglutide Ameliorates Intrauterine Adhesion by Suppressing Inflammation and Epithelial-Mesenchymal Transition via Inhibiting the TGF-β/Smad2 Signaling Pathway
by: Yifan Wang, et al.
Published: (2023)

Effects of once-weekly dulaglutide on juvenile type 2 diabetes mellitus and obesity in Korea: a pilot study
by: Ji Young Seo, et al.
Published: (2023)

Tirzepatide - a new analogue of incretin hormones
by: Gabriela Anglart, et al.
Published: (2023)

Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIP
by: Wang L
Published: (2022)

Safety and efficacy of using cereal food (Frugra®) to improve blood pressure and bowel health in patients undergoing chronic hemodialysis: A pilot study
by: Hajime Nagasawa, et al.
Published: (2021)

Commentary on "Effects of once-weekly dulaglutide on juvenile type 2 diabetes mellitus and obesity in Korea: a pilot study"
by: Han Hyuk Lim
Published: (2023)

Bullous pemphigoid triggered by dulaglutide: a case report and a review of the literature
by: Benedetta Sonego, et al.
Published: (2023)

The use of the GLP-1 analog - dulaglutide in the treatment of morbid obesity - case report
by: Agata Juda, et al.
Published: (2022)

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study
by: Torre E, et al.
Published: (2020)

Efficacy and safety of tirzepatide in patients with type 2 diabetes: A systematic review and meta-analysis
by: Yan Tang, et al.
Published: (2022)

Tirzepatide: Does the Evidence to Date Show Potential for the Treatment of Early Stage Type 2 Diabetes?
by: Razzaki TS, et al.
Published: (2022)

Tirzepatide's innovative applications in the management of type 2 diabetes and its future prospects in cardiovascular health
by: Jingqi Yang, et al.
Published: (2024)

Semaglutide versus Tirzepatide - comparison of both drugs in treatment of diabetes type 2 and weight reduction
by: Arkadiusz Staroń, et al.
Published: (2024)

Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide
by: Karen Schneck, et al.
Published: (2024)

Tirzepatide - a new hope for type 2 diabetes mellitus and obesity management. A literature review.
by: Izabela Stawicka, et al.
Published: (2024)

Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A bayesian network meta-analysis
by: Ruifang Guan, et al.
Published: (2022)

A pharmacokinetic study comparing the biosimilar HEC14028 and Dulaglutide (Trulicity®) in healthy Chinese subjects
by: Xianglei Gao, et al.
Published: (2024)

Cost-Utility Analysis of Once-Weekly Semaglutide, Dulaglutide, and Exenatide for Type 2 Diabetes Patients Receiving Metformin-Based Background Therapy in China
by: Shanshan Hu, et al.
Published: (2022)

Will Tirzepatide become a game-changer in the pharmacological treatment of obesity? - literature review
by: Aleksandra Doryń, et al.
Published: (2024)

The effect of zingiber officinale on prooxidant-antioxidant balance and glycemic control in diabetic patients with ESRD undergoing hemodialysis: a double-blind randomized control trial
by: Helya Rostamkhani, et al.
Published: (2023)

Evaluation and comparison of efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes mellitus: A Bayesian network meta-analysis
by: Yanan Ding, et al.
Published: (2024)

Preventive Effects of Dulaglutide on Disuse Muscle Atrophy Through Inhibition of Inflammation and Apoptosis by Induction of Hsp72 Expression
by: Tram Thi Ngoc Nguyen, et al.
Published: (2020)

Efficacy and Safety of Injectable Dulaglutide 1.5 mg Among Type 2 Diabetes Patients in Clinics at King Saud Medical City, Riyadh, Saudi Arabia
by: Mashael Saad Albargawi, et al.
Published: (2024)

Hemodialysis as a rite of transition
by: Esperanza Vélez Vélez
Published: (2006)

GLYCEMIC RESPONSE AND GLYCEMIC INDEX OF BANGLADESHI HONEY IN TYPE 2 DIABETIC PATIENTS
by: MD. IBRAHIM KHALIL, et al.
Published: (2006)

Safety profile of tirzepatide: A real-world pharmacovigilance analysis of EudraVigilance database
by: Atul Khurana, et al.
Published: (2024)

Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue
by: Ricardo J. Samms, et al.
Published: (2022)

Revolutionizing Diabetes and Obesity Management: A Comprehensive Review of Tirzepatide's Dual Agonist Approach
by: Sonam Samal, et al.
Published: (2024)

Effect of blood pressure and glycemic control on the plasma cell-free DNA in hemodialysis patients
by: Da Wun Jeong, et al.
Published: (2015)

Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Phase II/III Trials
by: Akshaya Srikanth Bhagavathula, et al.
Published: (2021)

The Burden of Caregivers of Patients Undergoing Hemodialysis
by: Maneesh Sharma, et al.
Published: (2021)

Spiritual Health in Patients undergoing Hemodialysis
by: N Shahgholian, et al.
Published: (2016)

Hypersensitivity to glucagon‐like peptide‐1 receptor agonists: A case of delayed urticaria‐like rash to dulaglutide and literature review
by: Leonardo Bianchi, et al.
Published: (2024)

Measurement of Plasma Glucagon Levels Using Mass Spectrometry in Patients with Type 2 Diabetes on Maintenance Hemodialysis
by: Yuta Yoshizawa, et al.
Published: (2021)

Lipidomic Analysis Reveals the Protection Mechanism of GLP-1 Analogue Dulaglutide on High-Fat Diet-Induced Chronic Kidney Disease in Mice
by: Martin Ho Yin Yeung, et al.
Published: (2022)

Prediction of pediatric dose of tirzepatide from the reference adult dose using physiologically based pharmacokinetic modelling
by: Ruifang Guan, et al.
Published: (2023)